Detalles de la búsqueda
1.
The Physiological Response of Apricot Flowers to Low-Temperature Stress.
Plants (Basel);
13(7)2024 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38611530
2.
Phase 1/2 multicenter trial of acalabrutinib in Chinese patients with relapsed/refractory mantle cell lymphoma.
Leuk Lymphoma;
65(5): 647-652, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557285
3.
Adaptively leverage multiple real-world data sources for treatment effect estimation based on similarity.
J Biopharm Stat;
: 1-11, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557411
4.
Pooled Analysis of Pralatrexate Single-Agent Studies in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma.
Blood Adv;
2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38429077
5.
Camrelizumab plus gemcitabine and oxaliplatin for relapsed or refractory classical Hodgkin lymphoma: a phase II trial.
BMC Med;
22(1): 107, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38454451
6.
Germline variants of DNA repair and immune genes in lymphoma from lymphoma-cancer families.
Int J Cancer;
155(1): 93-103, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38446987
7.
The mediating role of impulsivity between sleep quality and suicidal ideation in adolescent population: a multicenter cross-sectional study in the northeastern Sichuan, China.
Front Psychiatry;
15: 1301221, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347878
8.
Immunotyping of peripheral blood lymphocytes by flow cytometry reveals Th cell as a potential prognostic biomarker for extranodal NK/T-cell lymphoma.
Ann Hematol;
103(5): 1643-1653, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38191717
9.
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study.
Clin Cancer Res;
30(7): 1248-1255, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38190117
10.
Autologous stem cell transplant for refractory and relapsed peripheral T-cell lymphoma: a retrospective study in China.
J Cancer;
15(2): 539-544, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38169559
11.
Phase I study of the Syk inhibitor sovleplenib in relapsed or refractory mature B-cell tumors.
Haematologica;
2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235512
12.
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study.
Lancet Oncol;
25(1): 117-125, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38092009
13.
Deciphering the pivotal role of people with high-frequency occupational animal exposure in antibiotic resistance transmission between humans and animals.
J Antimicrob Chemother;
79(1): 27-35, 2024 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37944030
14.
Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
Ann Hematol;
103(1): 163-174, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37817010
15.
Tislelizumab and radiation therapy in low-risk early-stage extranodal natural killer/T-cell lymphoma, nasal type: a phase II study protocol.
Future Oncol;
20(5): 245-256, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38018460
16.
Glofitamab monotherapy induces high complete response rates and manageable safety in Chinese patients with heavily pretreated relapsed or refractory diffuse large B-cell lymphoma.
Haematologica;
109(4): 1269-1273, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855035
17.
Management and clinical outcomes of follicular lymphoma across continuous lines of treatments: a retrospective analysis in China.
Front Oncol;
13: 1264723, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37941553
18.
Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies.
Exp Hematol Oncol;
12(1): 92, 2023 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37845755
19.
Trends and determinants of place of death among Chinese lymphoma patients: a population-based study from 2013-2021.
Am J Cancer Res;
13(9): 4246-4258, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37818048
20.
Safety and immunogenicity of the COVID-19 mRNA vaccine CS-2034: A randomized, double-blind, dose-exploration, placebo-controlled multicenter Phase I clinical trial in healthy Chinese adults.
J Infect;
87(6): 556-570, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37898410